Search for "Cell therapy" in article titles:

  1. Cell therapy: Articles Most recent articles on Cell therapy Most cited articles on Cell therapy Review articles on Cell therapy Articles on Cell therapy in N Eng J Med, Lancet, BMJ Media Powerpoint slides on Cell therapy Images of Cell therapy Photos ... [100%] 2023-04-07 [Biotechnology] [Cell biology]...
  2. TK cell therapy: TK is an experimental cell therapy which may be used to treat high-risk leukemia. It is currently undergoing a Phase III clinical trial to determine efficacy and clinical usefulness. [81%] 2022-07-10 [Biotechnology]
  3. Stem-cell therapy: Stem-cell therapy uses stem cells to treat or prevent a disease or condition. As of 2024, the only FDA-approved therapy using stem cells is hematopoietic stem cell transplantation. (Use of stem cells to treat or prevent a disease or condition) [81%] 2025-03-04 [Quality assurance] [Accreditation in healthcare]...
  4. T cell receptor T cell therapy: T cell receptor T cell therapy (TCR-T) is a type of cancer immunotherapy. TCR-T therapies use heterodimers made of alpha and beta peptide chains to recognize MHC-presented polypeptide fragments molecules. [69%] 2023-01-18 [Cancer immunotherapy] [T cells]...
  5. T cell receptor T cell therapy: T cell receptor T cell therapy (TCR-T) is a type of cancer immunotherapy. TCR-T therapies use heterodimers made of alpha and beta peptide chains to recognize MHC-presented polypeptide fragments molecules. (Type of cancer immunotherapy) [69%] 2024-05-26 [Cancer immunotherapy] [T cells]...
  6. Sickle-cell disease medical therapy: Home Patient Information Overview Historical Perspective Classification Pathophysiology Causes Differentiating Sickle-cell disease from other Diseases Epidemiology & Demographics Risk Factors Screening Natural History, Complications & Prognosis Diagnosis History & Symptoms Physical Examination Laboratory Findings X Ray CT MRI Echocardiography or Ult. [63%] 2023-04-15
  7. Hilus cell tumor medical therapy: Home Patient Information Overview Historical Perspective Classification Pathophysiology Causes Epidemiology and Demographics Risk Factors Screening Differentiating Hilus cell tumor from other Diseases Natural History, Complications and Prognosis Diagnosis Staging History and Symptoms Physical Examination Laboratory Findings Chest X Ray CT ... [63%] 2023-04-08 [Disease] [Types of cancer]...
  8. Cardiovascular Cell Therapy Research Network: Cardiovascular Cell Therapy Research Network (CCTRN) is a network of physicians, scientists, and support staff dedicated to studying stem cell therapy for treating heart disease. The CCTRN is funded by the National Institutes of Health (NIH) and includes expert researchers ... (Biology) [63%] 2022-06-22 [Stem cells]
  9. Basal cell carcinoma medical therapy: Home Patient Information Overview Historical Perspective Classification Pathophysiology Causes Differentiating Basal Cell Carcinoma from other Diseases Epidemiology and Demographics Risk Factors Screening Natural History, Complications and Prognosis Diagnosis Diagnostic Study of Choice Staging History and Symptoms Physical Examination Laboratory Fin. [63%] 2023-04-04 [Up-To-Date] [Oncology]...
  10. Transfusion therapy (Sickle-cell disease): Red blood cells (erythrocytes) from donors contain normal hemoglobin (HbA), and transfusion of normal red blood cells into people with sickle cell disease reduces the percentage of red cells in the circulation containing the abnormal hemoglobin (HbS). Although transfusion of ... (Medicine) [63%] 2023-11-16 [Transfusion medicine] [Hematology]...
  11. Mast cell leukemia medical therapy: Home Patient Information Overview Historical Perspective Classification Pathophysiology Causes Differentiating Mast cell leukemia from other Diseases Epidemiology and Demographics Risk Factors Screening Natural History, Complications and Prognosis Diagnosis Staging History and Symptoms Physical Examination Laboratory Findings Chest X Ray CT ... [63%] 2023-03-25
  12. Acinic cell carcinoma medical therapy: Home Patient Information Overview Historical Perspective Classification Pathophysiology Causes Differentiating Acinic cell carcinoma from other Diseases Epidemiology and Demographics Risk Factors Screening Natural History, Complications and Prognosis Diagnosis Diagnostic Study of Choice History and Symptoms Physical Examination Laboratory Findings X. [63%] 2023-03-24 [(name of the system)]
  13. Merkel cell cancer medical therapy: Home Patient Information Overview Historical Perspective Classification Pathophysiology Causes Differentiating Merkel Cell Cancer from other Diseases Epidemiology and Demographics Risk Factors Screening Natural History, Complications and Prognosis Diagnosis Staging History and Symptoms Physical Examination Laboratory Findings CT Other Imaging Findin. [63%] 2023-03-07 [Disease] [Types of cancer]...
  14. Reticulum cell sarcoma medical therapy: Please help WikiDoc by adding more content here. It's easy!. [63%] 2023-05-11 [Disease] [Hematology]...
  15. Anaplastic large cell lymphoma medical therapy: Home Patient Information Overview Historical Perspective Classification Pathophysiology Causes Differentiating Anaplastic large cell lymphoma from other Diseases Epidemiology and Demographics Risk Factors Screening Natural History, Complications and Prognosis Diagnosis Diagnostic Study of Choice History and Symptoms Physical Examination Laboratory F. [57%] 2023-10-28 [Hematology] [Types of cancer]...
  16. Hairy cell leukemia medical therapy overview: Home Patient Information Overview Historical Perspective Classification Pathophysiology Causes Differentiating Hairy cell leukemia from other Diseases Epidemiology and Demographics Risk Factors Screening Natural History, Complications and Prognosis Diagnosis Diagnostic Study of Choice Staging History and Symptoms Physical Examination Laboratory Find. [57%] 2023-04-22 [Disease] [Types of cancer]...
  17. T-cell prolymphocytic leukemia medical therapy: Home Patient Information Overview Historical Perspective Classification Pathophysiology Causes Differentiating T-cell prolymphocytic leukemia historical perspective from other Diseases Epidemiology and Demographics Risk Factors Screening Natural History, Complications and Prognosis Diagnosis Diagnostic Study of Choice History and Symptoms Physical E. [57%] 2023-05-16 [Blood disorders] [Disease]...
  18. Angioimmunoblastic T-cell lymphoma medical therapy: Home Patient Information Overview Historical Perspective Classification Pathophysiology Causes Differentiating Angioimmunoblastic T-cell lymphoma from other Diseases Epidemiology and Demographics Risk Factors Screening Natural History, Complications and Prognosis Diagnosis Diagnostic Study of Choice History and Symptoms Physical Examination Laborato. [57%] 2023-06-23 [Hematology] [Types of cancer]...
  19. Renal cell carcinoma cost-effectiveness of therapy: Home Patient Information Overview Historical Perspective Classification Pathophysiology Causes Differentiating Renal cell carcinoma from other Diseases Epidemiology and Demographics Risk Factors Screening Natural history, Complications and Prognosis Diagnosis Staging Diagnostic Study of Choice History and Symptoms Physical Examination Laboratory Fin. [53%] 2023-05-23 [Needs content] [Kidney diseases]...
  20. Langerhans cell histiocytosis cost-effectiveness of therapy: Home Patient Information Overview Historical Perspective Classification Pathophysiology Causes Differentiating Langerhans cell histiocytosis from other Diseases Epidemiology and Demographics Risk Factors Screening Natural History, Complications and Prognosis Diagnosis History and Symptoms Physical Examination Laboratory Findings Chest X Ray CT MRI ... [53%] 2023-03-27 [Needs content] [Disease]...
  21. Reticulum cell sarcoma cost-effectiveness of therapy: Please help WikiDoc by adding content here. It's easy!. [53%] 2023-04-09 [Disease] [Hematology]...
  22. Non small cell lung cancer medical therapy: Home Patient Information Overview Historical Perspective Classification Pathophysiology Causes Differentiating Non Small Cell Lung Cancer from other Diseases Epidemiology and Demographics Risk Factors Screening Natural History, Complications and Prognosis Diagnosis Diagnostic Study of Choice History and Symptoms Physical Examination Laboratory ... [53%] 2023-04-20 [Disease] [Types of cancer]...
  23. Hairy cell leukemia cost-effectiveness of therapy: Home Patient Information Overview Historical Perspective Classification Pathophysiology Causes Differentiating Hairy cell leukemia from other Diseases Epidemiology and Demographics Risk Factors Screening Natural History, Complications and Prognosis Diagnosis Diagnostic Study of Choice Staging History and Symptoms Physical Examination Laboratory Find. [53%] 2023-07-16 [Disease] [Types of cancer]...
  24. Hilus cell tumor cost-effectiveness of therapy: Home Patient Information Overview Historical Perspective Classification Pathophysiology Causes Epidemiology and Demographics Risk Factors Screening Differentiating Hilus cell tumor from other Diseases Natural History, Complications and Prognosis Diagnosis Staging History and Symptoms Physical Examination Laboratory Findings Chest X Ray CT ... [53%] 2023-06-22 [Disease] [Types of cancer]...
  25. Mantle cell lymphoma cost-effectiveness of therapy: Home Patient Information Overview Historical Perspective Classification Pathophysiology Causes Differentiating Mantle cell lymphoma from other Diseases Epidemiology and Demographics Risk Factors Screening Natural History, Complications and Prognosis Diagnosis Diagnostic Study of Choice Staging History and Symptoms Physical Examination Laboratory Fin. [53%] 2023-05-31 [Blood disorders] [Types of cancer]...
  26. B-cell lymphoma cost-effectiveness of therapy: Home Patient Information Overview Historical Perspective Classification Pathophysiology Causes Differentiating B-cell lymphoma from other Diseases Epidemiology and Demographics Risk Factors Natural History, Complications and Prognosis Diagnosis Diagnostic Study of Choice History and Symptoms Physical Examination Laboratory Findings Electrocardiogram. [53%] 2023-04-21 [Needs content] [Disease]...
  27. Extranodal NK-T-cell lymphoma medical therapy: Home Patient Information Overview Historical Perspective Classification Pathophysiology Causes Differentiating Extranodal NK-T-cell lymphoma from other Diseases Epidemiology and Demographics Risk Factors Screening Natural History, Complications and Prognosis Diagnosis Staging Diagnostic Study of Choice History and Symptoms Physical Examination ... [53%] 2023-05-31 [Disease] [Types of cancer]...
  28. Diffuse large B cell lymphoma medical therapy: Home Patient Information Overview Historical Perspective Classification Pathophysiology Causes Differentiating Diagnosis Epidemiology and Demographics Risk Factors Screening Natural History, Complications and Prognosis Diagnosis Diagnostic Study of Choice History and Symptoms Physical Examination Laboratory Findings Electrocardiogram Chest X Ray CT. [53%] 2023-04-20 [Disease] [Types of cancer]...
  29. Basal cell carcinoma cost-effectiveness of therapy: Home Patient Information Overview Historical Perspective Classification Pathophysiology Causes Differentiating Basal Cell Carcinoma from other Diseases Epidemiology and Demographics Risk Factors Screening Natural History, Complications and Prognosis Diagnosis Diagnostic Study of Choice Staging History and Symptoms Physical Examination Laboratory Fi. [53%] 2023-04-11 [Needs content] [Disease]...
  30. Aggressive NK-cell leukemia cost-effectiveness of therapy: Home Patient Information Overview Historical Perspective Classification Pathophysiology Causes Differentiating Aggressive NK-cell leukemia from other Diseases Epidemiology and Demographics Risk Factors Natural History, Complications and Prognosis Diagnosis History and Symptoms Physical Examination Laboratory Findings CT Other Imaging Findings Other. [50%] 2023-03-23 [Needs content] [Disease]...

external From search of external encyclopedias:

0